During the development of neuronal circuits, axonal growth cones can contact many inappropriate targets before they reach an appropriate postsynaptic partner. Although it is well known that the contact with synaptic partners upregulates the secretory machinery of the presynaptic neuron, little is known about the signaling mechanisms involved in preventing the formation of connections with inappropriate target cells. Here, we show that the contact with a nonphysiological postsynaptic target inhibits neurotransmitter release from axonal terminals of the Helix serotonergic neuron C1 by means of an active mechanism requiring ongoing protein synthesis and leading to the inhibition of cAMP-dependent protein kinase (PKA) and mitogen-activated protein kinase (MAPK)-extracellular signal-related kinase (Erk) pathways. The reversal of the inhibitory effect of the nonphysiological target by blockade of protein synthesis was prevented by cAMP-PKA or MAPK-Erk inhibitors, whereas disinhibition of neurotransmitter release promoted by cAMP-PKA activation was not affected by MAPK-Erk inhibitors. The data indicate that the inhibitory effect of the nonphysiological target on neurotransmitter release is an active process that requires protein synthesis and involves the downregulation of the MAPK-Erk and cAMP-PKA pathways, the same protein kinases that are activated after contact with a physiological target neuron. These mechanisms could play a relevant role in the prevention of synapse formation between inappropriate partners by modulating the neurotransmitter release capability of growing nerve terminals according to the nature of the targets contacted during their development.
Introduction
During axon elongation, growth cones can contact inappropriate targets before reaching their physiological postsynaptic partner(s) and establishing synaptic connections. It is well known that contact with appropriate targets induces the morphological and functional maturation of presynaptic terminals by means of retrograde signals, originating from contact-mediated interactions or from the release of diffusible molecules such as trophic factors and neurotransmitters (Hall and Sanes, 1993; Dan and Poo, 1994; Fitzsimonds and Poo, 1998; Munno and Syed, 2003) , activating specific signal transduction pathways in the presynaptic neurons including cAMP-dependent protein kinase (PKA), mitogen-activated protein kinases (MAPKs), and tyrosine kinases (Dai and Peng, 1993; Funte and Haydon, 1993; Zoran et al., 1993; Hamakawa et al., 1999) .
We have previously studied the modulation exerted by the target neuron on the development of the presynaptic cell by using as an experimental model the serotonergic neuron C1 of the land snail Helix cocultured in contact with a physiological or nonphysiological target (Cibelli et al., 1996; Ghirardi et al., 2000 Ghirardi et al., , 2001 . In the presence of its physiological target B2, the neuron C1 presented a large number of varicosities containing neurotransmitter and synaptic vesicle proteins and formed chemical synaptic connections. On the contrary, the contact with a nonphysiological target such as the motoneuron C3 induced a dramatic reduction in the number of varicosities, an alteration in the distribution of synaptic vesicle proteins, and a decrease in evoked neurotransmitter release even with respect to a C1 neuron cultured in isolation. The inhibitory effect of the nonphysiological target on neurotransmitter release was reversed by a few minutes of contact with the physiological target B2, which induced an increase of neurotransmitter release associated with the formation of new varicosities. This buildup of transmitter release triggered by the physiological target was prevented by preincubation of the target neuron with an antibody against the Aplysia cell adhesion molecule (apCAM) (Keller and Schacher, 1990) . Although protein synthesis and the activation of several signal transduction pathways are known to be involved both in synaptogenesis (Feng et al., 1997; Hamakawa et al., 1999) and in many forms of long-term synaptic plasticity (Montarolo et al., 1986 (Montarolo et al., , 1988 Frey et al., 1993) , their role in preventing the formation of inappropriate synaptic connections during development and regeneration still has to be elucidated in detail.
To better understand the molecular mechanisms involved in the inhibition of synapse formation between inappropriate partners, we analyzed the role of protein synthesis as well as of the cAMP-PKA, MAPK-extracellular signal-related kinase (Erk), and tyrosine kinase pathways in the inhibitory effects exerted by the contact with a nonphysiological target on neurotransmitter release from the terminals of the Helix neuron C1 in culture. Here, we show that the contact with a nonphysiological target cell inhibits neurotransmitter release from developing terminals by means of an active mechanism requiring ongoing protein synthesis and leading to the inhibition of the same protein kinases that mediate the enhancement of neurotransmitter release triggered by contact with a physiological target.
Materials and Methods

Materials. Cell-labeling grade [
35 S]methionine (specific activity Ͼ1000 Ci/mmol) was from Amersham Biosciences (Milan, Italy). Nitrocellulose membranes (pore size 0.22 m) were from Schleicher and Schuell (Milan, Italy). The following antibodies were used: rabbit polyclonal antibody against MAPK-Erk-2 (C-14) (Santa Cruz Biotechnology, Santa Cruz, CA); mouse monoclonal anti-phosphotyrosine antibody (Upstate Biotechnology, Lake Placid, NY); polyclonal antibody against c-Jun NH 2 -terminal kinase (Jnk-1/2) (New England Biolabs, Beverly, MA); phosphorylation state-specific polyclonal antibody against the active form (P-Thr 183 /P-Tyr 185 ) of MAPK-Erk-1/2 and against the active form (P-Thr 183 /P-Tyr 185 ) of Jnk-1/2 (Promega, Madison, WI); and horseradish peroxidase-conjugated anti-rabbit or anti-mouse secondary antibodies were (Bio-Rad, Milan, Italy). The chemiluminescence detection system (Renaissance Western Blot Chemiluminescence Reagent Plus) was from New England Nuclear (Brussels, Belgium). Culture reagents, protein synthesis inhibitors, adenosine-3Ј,5Ј-monophosphorothioate, Sp isomer (Sp-cAMPS), adenosine-3Ј5Ј-monophosphorothioate, Rp isomer (Rp-cAMPS), forskolin, 3-isobutyl-1-methylxanthine (IBMX), genistein, lavendustin, and U0126 were from Sigma (Milan, Italy). 2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one (PD98059) was obtained from Promega, and TGF-␤1 from R & D Systems (Minneapolis, MN). All other chemicals, obtained from standard commercial suppliers, were of reagent grade.
Cell culture. All experiments were performed on identified cultured neurons of Helix pomatia. The cell culture technique of Helix neurons has been described previously by Ghirardi et al. (1996) . Briefly, after protease treatment (10 mg/ml protease IX), neurons C1 and C3 from the cerebral ganglion and B2 from the buccal ganglion of juvenile animals were individually dissociated by using a thin glass micropipette and plated in dishes coated with poly-L-lysine (0.5 mg/ml in 0.1 M sodium tetraborate, pH 8.2) as a substrate and preincubated in Aplysia hemolymph for 24 hr. The cells were cultured for 3-4 d in L15 Leibovitz medium (with appropriate salt concentrations) at 18°C. Under this condition, neurons adhere to the substrate and extend new neurites. We prepared cultures containing isolated C1 neurons as well as cocultures of the C1 neuron in contact with either its physiological target B2 (C1B2) or the nonphysiological target C3 (C1C3) with which it does not form electrical or chemical connections in vivo.
Electrophysiology and detection of neurotransmitter release. The synaptic connection between C1 and B2 has been tested electrophysiologically by intracellular recording of the postsynaptic B2 neuron depolarization (hyperpolarized to Ϫ80 mV) after an intracellular stimulation of C1 to fire action potentials at 10 Hz for 10 sec by using glass micropipettes filled with 2.5 M KCl (10 -15 M⍀) connected to an Axoclamp preamplifier in bridge mode. The resting membrane potential of the C1 and B2 neurons was between Ϫ45 and Ϫ50 mV, and neurons having membrane potential that changed Ͼ5 mV from the beginning to the end of the recording were not included in the study. All of the experiments were performed at room temperature. The secretory properties of the serotonergic C1 terminals were analyzed by adding a freshly dissociated sniffer neuron B2 to the 3-to 4-d-old C1C3 cocultures. The sniffer was impaled with a glass microelectrode for intracellular recording and micromanipulated in close contact with the neurites of C1 and left there throughout the experiment. Serotonin release was evoked by electrical stimulation of C1 (10 Hz for 10 sec) every 5 min and measured as the extent of depolarization recorded in the B2 sniffer. Because the basal release was very low when C1 was cocultured in the presence of the wrong target C3, the high-frequency stimulation was necessary to evoke a detectable depolarization in the B2 sniffer. Moreover, in the intact animal, C1 neurons are known to discharge at high frequencies in response to a chemical stimulation of the snail lips (Balaban, 2002) .
Pharmacological treatments. To block protein synthesis, cultures were treated with either 10 M anisomycin for 2 hr or 0.6 M cycloheximide for 5 hr. Cells were treated with the cAMP competitive antagonist RpcAMPS (500 M) for 30 min to inhibit the PKA pathway, with genistein (100 M) or lavendustin (10 M) for 2 hr to inhibit tyrosine kinases, or with U0126 or PD98059 (50 M) for 2 hr to block the MAPK-Erk pathway. To stimulate the PKA pathway, cultured neurons were treated either with the cAMP analog Sp-cAMPS (500 M) plus IBMX (500 M) or with forskolin (50 M) for 30 min. Stimulation of the MAPK-Erk pathway was performed by treating the cells with 10 ng/ml TGF-␤1 for 5-15 min. The ability of genistein to inhibit tyrosine phosphorylation in Helix neurons was assessed by incubating dissociated neurons in the absence or presence of 100 M genistein for 2 hr and then testing the tyrosine phosphorylation state of the extracted protein samples by immunoblotting with anti-phosphotyrosine antibodies (data not shown).
In vivo protein labeling of cultured Helix neurons with [ 35 S]methionine. Neurons from the Helix cerebral ganglion were dissected out and plated at a cell density of 50 -60 cells per dish in L15 medium 4 d before metabolic labeling. Dishes (six per experimental group) were subjected to the following sequential incubations: (1) complete L15 medium for 1 hr followed by methionine-free L15 medium containing 0.1 mCi per dish [ 35 S]methionine for 2 hr (control group); (2) complete L15 medium containing 10 M anisomycin for 1 hr followed by methionine-free L15 medium containing 10 M anisomycin and 0.1 mCi per dish [
35 S]methionine for 2 hr (anisomycin-treated group); (3) complete L15 medium containing 10 M anisomycin for 3 hr followed by complete L15 medium for 1 hr and by methionine-free L15 medium containing 0.1 mCi per dish [ 35 S]methionine for 2 hr (anisomycin recovery group). All incubations were performed at room temperature. After metabolic labeling, cells were washed thoroughly with saline and solubilized in 1% SDS and boiled for 2 min. Samples containing equal amounts of total protein were subjected to SDS-PAGE (Laemmli, 1970) on 9% polyacrylamide resolving gels. Proteins separated on the gels were electrophoretically transferred to nitrocellulose membranes (Towbin et al., 1979) and autoradiographed on Kodak X-Omat films. Labeled protein bands in the various molecular weight ranges were excised from the membranes and counted by liquid scintillation spectrometry. The metabolic labeling experiments were repeated three times with different culture preparations and [
35 S]methionine batches.
Immunoblotting assays. Freshly dissected neurons from the Helix cerebral ganglia were treated with various drugs at room temperature according to the experimental protocol. After the treatment, neurons were washed in L15 medium and homogenized by sonication (XL-2020 sonifier, power 4, 10 pulses; Misonix Inc., Farmingdale, NY) in boiling 1% SDS/1 mM sodium orthovanadate/2 mM sodium fluoride/2 mM sodium pyrophosphate. Aliquots of the solubilized samples were taken for total protein determination, and the rest was boiled for 2 min after addition of concentrated Laemmli sample buffer. Samples containing equal amounts of total proteins (15-30 g) were subjected to SDS-PAGE and transferred to nitrocellulose membranes as described above. Immunoblotting was performed as described previously (Tancredi et al., 2000) . Membranes were blocked in Tris-buffered saline (50 mM Tris-Cl, 200 mM NaCl, pH 7.4)/5% (w/w) nonfat dry milk or 5% BSA (in the case of phospho-specific antibodies) and incubated overnight at 4°C with the following concentrations of primary antibodies: anti-total MAPK-Erk2, 0.05 g/ml; anti-(P-Thr 183 /P-Tyr 185 )MAPK-Erk-1/2, 0.025 g/ml; anti-total Jnk-1/2, 1:1000; anti-(P-Thr 183 /P-Tyr 185 ) Jnk-1/2, 1:1000. Af-ter wash and incubation with horseradish peroxidase-conjugated goat anti-rabbit secondary antibodies (1:3000 -1:10,000 dilution), immunoreactivity was detected using the chemiluminescence system and autoradiography. Before the immunoblots were performed with phosphorylation state-specific antibodies, the total kinase immunoreactivity was quantified using a brain homogenate standard curve as a reference system, and the samples were normalized to contain the same amounts of total kinases. Other procedures. Protein concentrations were determined using the BCA assay (Pierce, Rockford, IL) with bovine serum albumin as standard. The results are expressed as means Ϯ SEM. Statistic significance was determined using the one-way or two-way ANOVA followed by the Newman-Keuls or the Dunnett multiple comparison test.
Results
Anisomycin blocks protein synthesis in Helix neurons
In other invertebrates such as Aplysia and Lymnaea, anisomycin has been effectively used to reversibly block protein synthesis (Montarolo et al., 1986; Feng et al., 1997) . To test whether protein synthesis is required for the target-dependent effects on the presynaptic neuron, we first checked the ability of an anisomycin treatment to block protein synthesis in Helix neurons ( Fig.  1 A, B) . Cultured Helix neurons were metabolically labeled with [
35 S]methionine in the absence or presence of anisomycin and after washout of the inhibitor (recovery). An almost total blockade of [
35 S]methionine incorporation was obtained with 2 hr incubation in 10 M anisomycin (3.3 Ϯ 0.5% with respect to control; p Ͻ 0.01) for all molecular weight classes of proteins as compared with control. The inhibition was promptly reversible, and a significant recovery in [
35 S]methionine incorporation, ranging from approximately ϩ60 to ϩ300% in the various molecular weight classes of proteins, was observed after anisomycin withdrawal (mean total value 177 Ϯ 12% with respect to control; p Ͻ 0.01). Treatment with high doses of anisomycin has been reported to induce cellular stress and affect cellular MAPK pathways by activating the stress-activated protein kinase Jnk-1/2 (Torocsik and Szeberenyi, 2000) . We then tested, at the dose used to block protein synthesis in cultured Helix neurons, whether anisomycin affected the phosphorylation state-activation of MAPK-Erk and Jnk. Immunoblotting of control and anisomycin-treated Helix ganglion neurons with phosphorylation state-specific antibodies (Fig. 1C) revealed that the treatment with anisomycin was not associated with changes in the activation of either MAPK-Erk or Jnk.
Protein synthesis is required for the inhibitory effect of the nonphysiological target
We have shown previously that the presence of the nonphysiological target C3 exerts a significant inhibitory effect on neurotransmitter release from the terminals of the Helix neuron C1 (Ghirardi et al., 2000 (Ghirardi et al., , 2001 . Immediately after the positioning of the B2 sniffer neuron in contact with the neurites of C1 (Fig. 2 A) , the mean depolarization recorded in the sniffer B2 evoked by C1 stimulation was ϳ12.2 Ϯ 1.55 mV (n ϭ 15) in the case of stimulation of isolated C1 neurons and ϳ14.1 Ϯ 2.3 mV (n ϭ 12) in the C1B2 cocultures (Fig. 2 B, C) . Such depolarization was dramatically reduced when C1 was cocultured with the nonphysiological target C3 to 1.82 Ϯ 0.2 mV (n ϭ 19; p Ͻ 0.001 vs the two former conditions). To investigate whether the inhibition of transmitter release attributable to the nonphysiological target was dependent on ongoing protein synthesis, the C1C3 cocultures were preincubated in 10 M anisomycin for 2 hr, a treatment that had no significant effect on the neurosecretory properties of the C1 neuron cultured in isolation or in contact with the physiological target B2 (data not shown). Interestingly, we found that the depolarization evoked in the B2 sniffer by stimulation of C1 neurons contacting the nonphysiological target C3 was significantly larger after anisomycin treatment (14.9 mV Ϯ 2.4; n ϭ 15; p Ͻ 0.001) as compared with the untreated C1C3 condition. Similar results were obtained after 5 hr of incubation with cycloheximide, another protein synthesis inhibitor (12.8 Ϯ 0.7 mV; n ϭ 6; p Ͻ 0.001) (Fig. 2C) . These values were similar to those recorded in the isolated C1 neurons or in the C1B2 cocultures in either the presence or absence of protein synthesis.
A significant, although less marked increase of neurotransmitter release after protein synthesis inhibition was also observed with shorter incubation times with inhibitors. The mean sniffer depolarization recorded after 30 and 60 min incubation with 10 M anisomycin was 4.08 Ϯ 0.49 mV (n ϭ 6) and 8.25 Ϯ 1.65 mV (n ϭ 4), respectively. These increases represent ϳ27 and 55% of the depolarization recorded in the sniffer B2 after C1 stimulation in the C1C3 coculture incubated with anisomycin for 2 hr (Fig.  2C ). These data suggest that the inhibitory effect of the nonphysiological target on neurotransmitter release is rapidly reversible and is attributable primarily to mechanisms that require ongoing protein synthesis.
Role of the cAMP-PKA system in the modulation of neurotransmitter release in the presence of a nonphysiological target Because several signal transduction pathways linked to PKA, MAPK, and tyrosine kinase activation have been implicated in the regulation of neuronal growth and synaptic plasticity (Bixby and Harris, 1991; Schmid et al., 1999; Purcell et al., 2003) , we next analyzed whether these pathways are also implicated in the inhibition of neurotransmitter release induced by contact with a nonphysiological target. Incubation of C1C3 cocultures with the cAMP analog Sp-cAMPS (500 M) in the presence of the phosphodiesterase inhibitor IBMX (500 M) induced an approximately ninefold increase of the sniffer depolarization evoked by C1 stimulation (18.2 Ϯ 2.5 mV; n ϭ 17) as compared with untreated C1C3 cocultures (2.0 Ϯ 0.2 mV; n ϭ 20; p Ͻ 0.001) (Fig.  3A) . A similar enhancement was observed after incubation with the adenylate cyclase activator forskolin (50 M) (12.6 Ϯ 1.1 mV; n ϭ 11). Such values were similar to those measured after stimulation of C1 neurons either isolated (12.19 Ϯ 1.11 mV; n ϭ 26) or in C1C3 cocultures treated with anisomycin (10.65 Ϯ 0.56 mV; n ϭ 10). This indicates that the wrong target-dependent inhibition of neurotransmitter release results from a downregulation of the cAMP-PKA cascade that requires ongoing protein synthesis. This hypothesis was further confirmed by the observation that application of the cAMP competitive antagonist RpcAMPS (500 M) to the C1C3 coculture did not affect neurotransmitter release of the C1 neuron in the presence of ongoing protein synthesis (mean sniffer depolarization 1.83 Ϯ 0.22 mV; n ϭ 9) but was able to completely abolish the stimulatory effect of anisomycin (2.3 Ϯ 0.3 mV; n ϭ 13) (Fig. 3A) .
Role of tyrosine kinases and MAPK-Erk systems in the modulation of neurotransmitter release in the presence of a nonphysiological target
To investigate the potential role of tyrosine kinases in the inhibition of neurotransmitter release induced by the wrong target, we incubated the C1C3 cocultures with the tyrosine kinase inhibitors genistein (100 M) or lavendustin (10 M), which have been previously demonstrated to be effective in Aplysia, Lymnaea, and Helix neurons (Hamakawa et al., 1999; Grinkevich et al., 2003; Purcell et al., 2003) . We found that tyrosine kinase inhibition did not significantly affect neurotransmitter release from the C1 neuron cultured in contact with the wrong target C3. The depolarization recorded in the B2 sniffer after C1 stimulation was 2.96 Ϯ 0.81 mV (n ϭ 7) and 3.81 Ϯ 0.47 mV (n ϭ 13) after genistein and lavendustin treatment, respectively. These values were closely similar to those recorded in untreated C1C3 cocultures (2.33 Ϯ 0.36 mV; n ϭ 6) and significantly different from those obtained after stimulation of the isolated C1 neuron (12 Ϯ 1.89 mV; n ϭ 6; p Ͻ 0.05). Moreover, tyrosine kinase inhibition did not affect the disinhibition of neurotransmitter release performed by anisomycin in C1C3 cocultures. In the presence of anisomycin, the depolarization recorded in the sniffer B2 after C1 stimulation was 10.67 Ϯ 1.59 mV (n ϭ 6) and 11.6 Ϯ 2.01 mV (n ϭ 5) for genistein and lavendustin treatment, respectively. These values were similar to those recorded in control experiments in which C1C3 cocultures were treated with anisomycin in the absence of tyrosine kinase inhibitors (10.5 Ϯ 1.52; n ϭ 6) (Fig. 3B) . These results suggest that tyrosine kinases are not directly involved in the inhibitory effect of the nonphysiological target on neurotransmitter release.
On the contrary, the stimulatory effect of anisomycin on neurotransmitter release from the C1 neurons contacting the nonphysiological target was virtually abolished when the MAPK-Erk pathway was inhibited by 50 M of the MAP kinase kinase (MEK) inhibitor U0126 or PD98059. The depolarization of the sniffer B2 evoked by the stimulation of C1 in anisomycin-treated C1C3 cocultures was ϳ12.14 Ϯ 1.52 mV (n ϭ 11; p Ͻ 0.01) compared with the value of 1.92 Ϯ 0.27 mV (n ϭ 20) recorded in the un- Figure 2 . The inhibitory effect of the nonphysiological target requires protein synthesis. A, Phase-contrast micrograph of C1 and C3 Helix neurons in culture with the freshly dissociated sniffer neuron B2. The neurons C1 and B2 were impaled with microelectrodes for intracellular current-clamp recording, and the sniffer cell B2 was micromanipulated in contact with the axonal terminals of C1 at the time of recording. Scale bar, 100 m. B, Representative traces of the depolarization recorded intracellularly in the sniffer B2 after C1 stimulation (10 sec at 10 Hz; horizontal bar) in C1, C1B2, and C1C3 cultures incubated in the absence or presence of anisomycin for 2 hr (AM). The B2 neuron was hyperpolarized to Ϫ80 mV. Calibration bars: 5 mV, 10 sec. C, Anisomycin and cycloheximide increased the depolarization recorded in the sniffer B2 4 after C1 stimulation in the presence of the nonphysiological target. The height of each bar represents the mean depolarization amplitude (ϮSEM) evoked by C1 stimulation and recorded in the B2 sniffer immediately after its contact with the neurites of the C1 neuron. The cultures containing the C1 neuron cultured alone (C1) or in the presence of the physiological target B2 (C1B2) or the nonphysiological target C3 (C1C3) were incubated in the absence or presence of anisomycin (AM) (10 M for 0.5, 1, or 2 hr) or cycloheximide (CH) (0.6 M for 5 hr). Statistical analysis indicates significant differences between the untreated C1C3 group and the other conditions (ANOVA: F (6,70) ϭ 10.19, p Ͻ 0.0001; Newman-Keuls multiple comparison test: p Ͻ 0.01).
treated C1C3 cocultures (Fig. 4 A) , whereas it was reduced to 2.3 Ϯ 0.5 mV (n ϭ 12; p Ͻ 0.01) after U0126 treatment and to 2.06 Ϯ 0.3 mV (n ϭ 8; p Ͻ 0.05) after PD98059 treatment. Such inhibitors were completely ineffective on the basal release of C1C3 cocultures in the absence of anisomycin (1.65 Ϯ 0.28 mV, n ϭ 6, and 1.91 Ϯ 0.47 mV, n ϭ 6, for U0126 and PD98059 treatments, respectively). Conversely, incubation of C1C3 cocultures with TGF-␤1 (10 ng/ml), a MAPK-Erk activator, induced a fivefold increase in the depolarization recorded in the sniffer B2 after C1 stimulation (11.5 Ϯ 1.5 mV; n ϭ 17) with respect to untreated C1C3 cocultures ( p Ͻ 0.001). The effect of TGF-␤1 was blocked by treatment with the MAPK inhibitor U0126, which significantly reduced the depolarization of the sniffer B2 evoked by C1 stimulation to 3.3 Ϯ 0.4 mV (n ϭ 6; p Ͻ 0.05), a value similar to that recorded in untreated C1C3 cocultures (Fig. 4 A) .
Immunoblotting analysis performed with phosphorylation state-specific antibodies in Helix ganglion neurons subjected to the same treatments revealed that MAPK-Erk is constitutively phosphorylated under basal conditions and its phosphorylation is stimulated markedly after treatment with TGF-␤1 and inhib- ited after treatment with U0126 alone or in association with TGF-␤1 (Fig. 4 B) . These treatments were specific for the MAPKErk pathway, because the phosphorylation state of Jnk-1/2 was not affected.
Interestingly, the inhibition of the MAPK-Erk cascade with U0126 did not affect the increase of neurotransmitter release from the C1 neuron in the presence of the wrong target induced by the cAMP-PKA pathway activator Sp-cAMPS (15.3 Ϯ 1.7 mV; n ϭ 7). Conversely, the increase in the C1 stimulation-evoked depolarization of the sniffer B2 induced after MAPK-Erk activation by TGF-␤1 was suppressed by the inhibitor of the cAMP-PKA pathway, Rp-cAMPS (5.3 Ϯ 0.5 mV; n ϭ 8; p Ͻ 0.05) (Fig. 4 A) .
The induction of neurotransmitter release by contact with the physiological target requires PKA and MAPK-Erk activation
The presence of the physiological target B2 stimulates the growth of the presynaptic neuron C1 and is able to overcome the inhibition of neurotransmitter release exerted by a cocultured nonphysiological target within 30 min of contact (Ghirardi et al., 2000 (Ghirardi et al., , 2001 . In fact, a 30 min contact of the sniffer B2 with the C1 neurites in C1C3 cocultures induced a significant increase in the amount of C1 stimulation-evoked depolarization recorded in the sniffer B2 from 1.77 Ϯ 0.17 mV immediately after contact up to 6.17 Ϯ 0.94 mV after 30 min of contact (n ϭ 6; p Ͼ 0.001) (Fig. 5) . To investigate whether this induction of neurotransmitter release by the physiological target was dependent on the same pathways involved in the inhibitory effect of the nonphysiological target, we treated the C1C3 cocultures with PKA or MAPK-Erk or tyrosine kinase inhibitors and analyzed the time course of the sniffer B2 depolarization evoked by C1 stimulation during the 30 min of contact with the physiological target. Treatment of C1C3 cocultures with the cAMP antagonist Rp-cAMPS completely prevented the stimulatory effect of the physiological target on neurotransmitter release (with changes in B2 depolarization from 1.83 Ϯ 0.22 mV immediately after the contact to 1.31 Ϯ 0.23 mV after 30 min; n ϭ 7). A similar prevention of the stimulatory effect of the physiological target on neurotransmitter release was observed with the MAPK-Erk inhibitors U0126 (with changes in the C1 stimulation-evoked depolarization of the B2 sniffer from 1.73 Ϯ 0.4 mV immediately after contact to 1.5 Ϯ 0.35 mV after 30 min; n ϭ 4) and PD98059 (with changes in the C1 stimulationevoked depolarization of the sniffer B2 from 1.2 Ϯ 0.4 mV immediately after contact to 1.6 Ϯ 0.35 mV after 30 min; n ϭ 4) (Fig.  5) . On the contrary, the tyrosine kinase inhibitor genistein did not significantly interfere with the upregulation of neurotransmitter release promoted by contact with the physiological target B2 in C1C3 cocultures. Similarly to untreated cultures, the depolarization of the sniffer B2 evoked by the stimulation of C1 in the presence of 100 M genistein increased significantly after 30 min of contact (from 2.96 Ϯ 0.7 mV immediately after contact to 8.14 Ϯ 1.9 mV after 30 min; n ϭ 7; p Ͻ 0.01) (Fig. 5) . Similar results were obtained with 10 M lavendustin (data not shown).
These results suggest that, in the presence of an inappropriate target, the induction of neurotransmitter release by the physiological target retrogradely activates the same signal transduction pathways involved in the wrong target-mediated inhibition.
Discussion
The data reported here show that interaction with a nonphysiological target results in the inhibition of evoked neurotransmitter release from nerve terminals of the Helix C1 neuron, an active process requiring the synthesis of new proteins and involving a downregulation of the MAPK-Erk and cAMP-PKA pathways. In fact, such inhibitory action was blocked by incubation of C1C3 cocultures with the protein synthesis inhibitors anisomycin and cycloheximide. Moreover, the inhibitory effect of the nonphysiological target was overcome by stimulation of either the cAMP-PKA or MAPK-Erk cascades or by prolonged contact with the physiological target B2. The latter effect was also prevented by the inhibition of either the cAMP-PKA or the MAPK-Erk pathway, indicating that these pathways represent a final common pathway through which postsynaptic targets control the maturation and efficiency of presynaptic neurotransmitter release mechanisms.
In our experiments, the inhibitory effect of the wrong target on neurotransmitter release from the C1 neuron was strictly modulated by the presence of the appropriate target neuron B2. The physiological target is able to remove the wrong targetinduced inhibition either after a 30 min contact with a preexisting C1C3 coculture, according to the ability of invertebrate neurons to rapidly form synaptic connections after contact between synaptic partners (Coulson and Klein 1997) , or when it is plated in contact with C1 simultaneously with the wrong target (C3C1B2 cocultures). The presence of the neuron B2 in C3C1B2 cocultures overrides the inhibitory effect of the wrong target on the formation of varicosities containing 5HT (Ghirardi et al., 2000) and induces a significant increase in the amount of neurotransmitter release as compared with the C1C3 cocultures (M. Ghirardi, unpublished observations) . On the other hand, the wrong target also fails to exert any inhibitory effect on neurotransmitter release when it is plated (for 0.5-2 hr) in contact with C1 neurons that have been grown in isolation or in contact with the appropriate target B2 for 3-4 d and have already developed an efficient releasing machinery. Adhesion molecules such as apCAMs have been shown to play important roles in the formation and maturation of neuronal connections and in synaptic plasticity in Aplysia (Mayford et al. 1992; Zhu et al., 1994 Zhu et al., , 1995 Schacher et al., 2000) through pathways involving MAP kinase activation (Bailey et al., 1997) . Because the blockade of the release-enhancing effect of the physiological target in Helix C1C3 cocultures by MAPK inhibitors is similar to the effect of incubation of the B2 neuron with antiapCAM antibodies (Ghirardi et al., 2001) , it is tempting to speculate that the signal transduction pathways activated by cell adhesion molecules could mediate the target-dependent effects on nerve terminal maturation. Possible targets of transmitter release modulation by apCAM-like molecules may be calcium channels, with changes in their functional properties and aggregation at release sites, or cytoskeletal proteins, because the cytoplasmic domains of N-CAM (neural cell adhesion molecule) and L1 are directly associated with ankyrins (Davis and Bennett, 1994) . In Drosophila, the clustering of the adhesion molecule fasciclin II with Shaker K ϩ channels mediated by the DLG/PSD (discs largepostsynaptic density)-95 family of MAGUKs (membrane associated guanylate kinases) can be involved in the modulation of the level of activity and neurotransmitter release in the presynaptic motor neuron terminals (Thomas et al., 1997) .
Several signal transduction pathways linked to PKA, PKC (protein kinase C), MAPK, and tyrosine kinase activation have been repeatedly implicated in the regulation of neuronal growth and synaptic plasticity in invertebrate as well as mammalian neurons with effects that are dependent, at least in part, on modulation of protein synthesis. Among them, the cAMP-PKA pathway appears to play a central role in several processes such as modulation of neuronal development and plastic changes underlying learning and memory (for review, see Silva et al., 1998; Kandel, 2001 ). In the presence of protein synthesis, we found that stimulation of the cAMP-PKA system is able to overcome the wrong target-dependent inhibitory effect on neurotransmitter release and that, conversely, its inhibition abolishes the releaseenhancing effect of the protein synthesis blockade. These findings strongly indicate that the cAMP-PKA system, by acting downstream of protein synthesis, plays a key role in mediating the target-dependent effects on the development and maturation of the exocytotic machinery and that a tonic PKA activity is required for a correct nerve terminal maturation. These results are in agreement with previous findings showing that contact with the appropriate target muscle cells induces a PKA-dependent increase of intracellular calcium in Helisoma neurons and that the positive effects of the synaptic vesicle-associated phosphoprotein synapsin in Xenopus neural development are strongly dependent on PKA phosphorylation (Kao et al., 2002) .
Although tyrosine kinases do not appear to participate in the target-dependent changes in our experimental model, a potential candidate in addition to PKA is the MAPK-Erk pathway. The MAPK pathway has been shown to regulate the formation of the Drosophila neuromuscular junction (Koh et al., 2002) and to phosphorylate proteins involved in transmitter release, such as synapsins (Angers et al., 2002) . In addition, MAPK-Erk has a fundamental role in many forms of synaptic plasticity, both in invertebrates (Bailey et al., 1997; Martin et al., 1997; Sharma et al., 2003) and in mammals (Kawasaki et al., 1999; Roberson et al., 1999; Huang et al., 2000; Zhang et al., 2003) . Similarly to what we observed for PKA, the stimulation of the MAPK-Erk in the presence of protein synthesis overcame the wrong target-induced inhibitory effect on neurotransmitter release, and conversely, its inhibition abolished the release-enhancing effect of the protein synthesis blockade. This suggests that the two pathways act synergistically downstream of protein synthesis. Interestingly, whereas MAPK-Erk activation is blocked by inhibition of the cAMP-PKA pathway, the effects of cAMP-PKA activation are not affected by MAPK-Erk blockade, indicating that the two pathways act on neurotransmitter release in series, rather than in parallel, with the cAMP-PKA system located downstream of the MAPK-Erk pathway.
Because a large body of experimental evidence suggests that novel protein synthesis is a requisite for the synapse to be formed (Montarolo et al., 1986; Feng et al., 1997; Martin et al., 2000; Schacher and Wu, 2002) and that contact with the physiological target is followed over time by an increase in transmitter release to a steady-state level (Grantyn et al., 1995; Cibelli et al., 1996; Verderio et al., 1999) , we propose that signals from the physiological target activate a set of proteins that, through the MAPKErk and cAMP-PKA pathways, upregulate transmitter release from the presynaptic neuron. Recent data have shown the existence of protein synthesis and RNA translation not only in the cell body of neurons but also in neurites and synaptic sites (Kang and Schuman, 1996; Martin et al., 1998; Sotelo et al., 1999; Alvarez et al., 2000; Sigrist et al., 2000; Schacher and Wu, 2002) . The presence of local protein synthesis in terminals could explain the rapidity of the anisomycin effect in increasing neurotransmitter release in C1C3 cocultures (Sherff and Carew, 2000; Wang et al., 2002; Zhang and Poo, 2002) .
In conclusion, the present data indicate that contact with a nonphysiological target can inhibit neurotransmitter release from developing presynaptic terminals by means of an active mechanism requiring ongoing protein synthesis and leading to the inhibition of the same protein kinases, namely MAPK-Erk and PKA, that are activated after contact with a physiological target cell. The evidence that PKA-and MAPK-Erk-dependent events lie downstream of protein synthesis suggests that contact with an inappropriate target could trigger the translation of some molecules with inhibitory effects on PKA and MAPK activity. It is tempting to speculate that inhibition of the PKA pathway could be achieved by increasing the expression of the PKA catalytic inhibitor peptide (Demaille et al., 1977; Beavo and Mumby 1981) , the PKA regulatory subunit RII, or some protein inhibiting the binding of RII to A kinase-anchoring proteins (AKAPs), a critical event for the correct compartmentalization of PKA within nerve terminals (Schwartz 2001) . Inhibition of the latter binding prevented both short-and long-term facilitation in Aplysia sensorimotor synapses, processes in which an enhanced phosphorylation of presynaptic proteins is required (Liu et al., 2004 ). Another possibility is that the wrong target-dependent inhibition induces an increased expression of dual specificity phosphatases regulating MAPK activity in an inhibitory way (Clarke, 1994; Nebreda, 1994) . Although the identity of the regulatory proteins involved remains to be elucidated, these mechanisms could represent a means for regulating the development of neuronal connectivity by preventing the formation of inappropriate connections.
